1 |
Ronnefarth G, Misselwitz J; Members of the Arbeitsgemeinschaft fur padiatrische Nephrologie. Nephrocalcinosis in children: a retrospective survey. Pediatr Nephrol 2000;14:1016-21.
DOI
|
2 |
Lietman SA, Germain-Lee EL, Levine MA. Hypercalcemia in children and adolescents. Curr Opin Pediatr 2010;22:508-15.
DOI
|
3 |
Gil A, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab 2018;72:87-95.
DOI
|
4 |
Vogiatzi MG, Jacobson-Dickman E, DeBoer MD; Drugs, and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 2014;99:1132-41.
DOI
|
5 |
Barnett ML. Hypercalcemia. Semin Oncol Nurs 1999;15:190-201.
DOI
|
6 |
Vaidya SR, Yarrarapu SNS, Aeddula NR. Nephrocalcinosis [Internet]. Treasure Island: StatPearls Publishing; 2021 Aug [cited 2022 Apr 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537205/.
|
7 |
Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int 2011;80:1278-91.
DOI
|
8 |
Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 2010;25:403-13.
DOI
|
9 |
Janiec A, Halat-Wolska P, Obrycki L, Ciara E, Wojcik M, Pludowski P, et al. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations. Nephrol Dial Transplant 2021;36:1484-92.
DOI
|
10 |
Marks BE, Doyle DA. Idiopathic infantile hypercalcemia: case report and review of the literature. J Pediatr Endocrinol Metab 2016;29:127-32.
|
11 |
Kang SJ, Lee R, Kim HS. Infantile hypercalcemia with novel compound heterozygous mutation in SLC34A1 encoding renal sodium-phosphate cotransporter 2a: a case report. Ann Pediatr Endocrinol Metab 2019;24:64-7.
DOI
|
12 |
De Paolis E, Scaglione GL, De Bonis M, Minucci A, Capoluongo E. CYP24A1 and SLC34A1 genetic defects associated with idiopathic infantile hypercalcemia: from genotype to phenotype. Clin Chem Lab Med 2019;57:1650-67.
DOI
|
13 |
Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410-21.
DOI
|
14 |
Moza D, Dasgupta K, Daskalopoulou S. Hypercalcemia and upper GI symptoms. Can J Gen Int Med 2018;13:51-2.
|
15 |
Lee GM, Moon JE, Kim HA, Lee SJ, Ko CW. A novel variant of SLC34A1 gene in an infant with idiopathic infantile hypercalcemia. ESPE Abstr 2018;89:P2-047.
|